We are live on ! Find out more
CYCN icon

Cyclerion Therapeutics
CYCN

103 hedge funds and large institutions have $223M invested in Cyclerion Therapeutics in 2019 Q2 according to their latest regulatory filings, with 103 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.55% more ownership

Funds ownership: 0% → 3.55% (+3.6%)

Holders
103
Holders Change
+103
Holders Change %
–
% of All Funds
2.24%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
103
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$38.7M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$29.8M
3
CCM
Camber Capital Management
Massachusetts
+$22.1M
4
MP
MFN Partners
Massachusetts
+$21.1M
5
BlackRock
BlackRock
New York
+$20.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$31.3M +$38.7M +136,862 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$24.1M +$29.8M +105,374 New
CCM
3
Camber Capital Management
Massachusetts
$17.9M +$22.1M +78,096 New
MP
4
MFN Partners
Massachusetts
$17M +$21.1M +74,394 New
BlackRock
5
BlackRock
New York
$16.9M +$20.9M +73,887 New
AG
6
Artal Group
Luxembourg
$15.6M +$19.3M +68,079 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$12.8M +$15.9M +56,017 New
BM
8
Bridger Management
New York
$11.8M +$14.6M +51,632 New
UBS AM
9
UBS AM
Illinois
$9.22M +$11.4M +40,278 New
EC
10
EcoR1 Capital
California
$8.89M +$11M +38,810 New
SPC
11
Slate Path Capital
New York
$8.18M +$10.1M +35,701 New
FCM
12
Farallon Capital Management
California
$6.23M +$7.7M +27,204 New
State Street
13
State Street
Massachusetts
$4.89M +$6.04M +21,357 New
Citadel Advisors
14
Citadel Advisors
Florida
$3.42M +$4.22M +14,922 New
SCM
15
Sarissa Capital Management
Connecticut
$2.86M +$3.54M +12,500 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.76M +$3.42M +12,072 New
BBA
17
Baker Bros. Advisors
New York
$2.32M +$2.87M +10,129 New
Northern Trust
18
Northern Trust
Illinois
$2.18M +$2.69M +9,508 New
Adage Capital Partners
19
Adage Capital Partners
Massachusetts
$2.15M +$2.65M +9,375 New
PAM
20
Panagora Asset Management
Massachusetts
$1.94M +$2.4M +8,486 New
T. Rowe Price Associates
21
T. Rowe Price Associates
Maryland
$1.74M +$2.15M +7,588 New
New York State Common Retirement Fund
22
New York State Common Retirement Fund
New York
$1.67M +$2.06M +7,290 New
N
23
Nuveen
North Carolina
$1.34M +$1.66M +5,854 New
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$1.25M +$1.55M +5,482 New
Charles Schwab
25
Charles Schwab
California
$1.14M +$1.41M +4,982 New
1
2 3 4 5

CYCN Hedge Fund Activity: Q2 2019 in Review

103 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Cyclerion Therapeutics (CYCN) for Q2 2019, worth a combined $223M.

Buyers outnumbered sellers: 103 funds opened new CYCN positions and 0 closed out — a net gain of 103 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $38.7M.

  • 103 institutional investors held Cyclerion Therapeutics (CYCN) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $223M of Cyclerion Therapeutics stock for Q2 2019.
  • 103 funds opened new Cyclerion Therapeutics positions in Q2 2019 and 0 closed out, a net change of +103 holders.
  • The largest Cyclerion Therapeutics buyer in Q2 2019 was Fidelity Investments, an estimated $38.7M added.

Based on aggregated 13F filings for Q2 2019.